Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Announces Completion Of Alios BioPharma Acquisition

[PR Newswire] – NEW BRUNSWICK, N.J., Nov. 7, 2014 /PRNewswire/ — Johnson & Johnson (JNJ) today announced the completion of the acquisition of Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical company . . . → Read More: Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Announces Completion Of Alios BioPharma Acquisition Similar Articles: Stock Update (NYSE:ABBV): AbbVie says $55 billion acquisition of Shire officially dead Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Reports 2014 Third-Quarter Results: Stock Update (NYSE:JNJ): FDA says Johnson & Johnson recalls some jaw implants